JUAN BECERRA: Open Payments
NPI 1679967640 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,838 in 81 payments from 19 companies in 2025. Trend: 2023 $1,986 · 2024 $2,763 · 2025 $1,838
Food & beverage: $1,838
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 19 | $315 |
| Novo Nordisk Inc | 6 | $292 |
| AstraZeneca Pharmaceuticals LP | 6 | $257 |
| Ardelyx, Inc. | 10 | $236 |
| Abbott Laboratories | 13 | $217 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Lilly USA, LLC | 4 | $72 |
| Exact Sciences Corporation | 3 | $60 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
Products named: JARDIANCE, Ozempic, IBSRELA, FREESTYLE LIBRE 3, FARXIGA, Kerendia, MOUNJARO, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
